Apps

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

IJR News — today's news from every side

Lilly's $2.9B deal adds treatments for Graves' disease and food allergies — Aug 31, 2026Eli Lilly is acquiring Merida Biosciences for about $2.88 billion in cash, expanding its immunology and allergic-disease pipeline beyond its obesity drugs, with the deal expected to close in Q4 2026 and marking Lilly’s ongoing aggressive M&A strategy. Merida’s lead program MER511 targets Graves’ disease and thyroid eye disease, while MER769 is in preclinical development for food allergy, asthma and chronic spontaneous urticaria, underscoring a broadened portfolio as Lilly references roughly $29 billion in upfront and milestone payments this year across acquisitions.

Lillard posts 1,100 of 1,168 shooting in offseason workout — Aug 29, 2026Portland's off-season overhaul includes trading for Ja Morant to pair with Damian Lillard and Jrue Holiday, creating one of the NBA's most intriguing backcourts as Lillard returns from an Achilles injury. Reports show Lillard converting 1,100 of 1,168 shots in recent workouts, signaling a strong, ready-to-play comeback for the 2026-27 season.

Lilly Plans $2.88B Merida Autoimmune AcquisitionBusiness — 3dEli Lilly is rapidly expanding beyond its obesity-and-diabetes blockbuster lineup, striking two multi-deal paths: a $2.875 billion-plus acquisition of Merida Biosciences to broaden its autoimmune and antibody-directed therapies, and a $3.83 billion spree to acquire three biotech firms—Curevo, LimmaTech Biologics, and Vaccine Company—to build a broader vaccine and infectious-disease pipeline. The moves underscore a strategy to diversify growth into immunology, infectious diseases, and autoantibody therapies while managing revenue risk from reliance on a small number of weight‑loss drugs.

Video — YouTubeMISTRIAL: MA v. Lindsay Clancy - Day 28 | Accused Killer Mom TrialCOURT TV · 3.4M views · Sep 4, 2026

Novo Nordisk launches Wegovy pill in Germany as Eli Lilly readies rival — 6dNovo Nordisk is rolling out Wegovy as an oral weight‑loss pill in Germany, the EU’s first market to receive the formulation after EU approval, with prices expected around €170–€280 and strong competition from Eli Lilly’s Foundayo on the horizon. The launch leverages Wegovy’s dominant position in the oral obesity market, while analysts weigh the impact of the tablet on growth, pricing, and payer access across Europe.

Tom Gallagher Curious how many insurers in Germany will actually cover this at launch, oral obesity meds still feel like they're priced for a niche market.

IJRAt Least Five Dead, Five Injured In Fatal Amazon Plane CrashSpencer Lombardo · 2 min · 10h

China obesity rate expected above 65% by 2030 — Aug 24, 2026China’s National Health Commission suggests obesity could exceed 65% of the population by 2030, triggering a push by major drugmakers to promote GLP-1 weight-loss injections through indirect public advertising in places like metro stations and stadiums due to bans on direct prescription-drug ads. Companies including Novo Nordisk, Lilly, Pfizer, and Innovent Biologics are vying for market share, with Lilly leading online sales on Alibaba/JD.com and campaigns emphasizing obesity risks and related conditions such as sleep apnea without naming products.

RankingMost underrated cities in AmericaAmerica's biggest cities hog all the spotlight, while dozens of smaller gems get overlooked despite great food, culture, and character. These underrated cities deserve recognition beyond the usual coastal favorites. Cast your vote and help crown the most underappreciated city in the country.693 votes · 21 candidates

Lilly Retatrutide Meets Endpoints in Phase 3 Trials — Jul 23, 2026Eli Lilly announced positive Phase 3 results for retatrutide in TRIUMPH-2 and TRIUMPH-3, showing substantial weight loss and improved metabolic and cardiovascular risk markers, with average losses ranging roughly from the high 20s to the mid-50s pounds across different doses. The company plans to submit a Biologics License Application to the FDA in early 2027 as it moves toward global regulatory submissions for obesity and related conditions.

Rice Partnership Raises Eli Lilly Stake to 20,667 Shares, 2.6% of PortfolioBusiness — Jul 21, 2026Rice Partnership LLC increased its Eli Lilly stake to 20,667 shares (~$19.0 million) and opened a new 7,783-share position in Cheniere Energy, while trimming its iShares MSCI Germany ETF holding to 618,221 shares (~$24.5 million) and adding a 31,967-share position in JPMorgan Municipal ETF (~$1.6 million) in the first quarter.

Popular Rom-Com Actress Jen Lilley Shares What Adoption Teaches About Being ‘Grafted in’ God’s LoveReporting — Jan 8, 2024When actress Jen Lilley is seen in Great American Family and Hallmark Channel romantic comedies, the script seems to have a way of coming out right in the end. In real life, she’s tried to provide that kind of happy…

China's Novo Nordisk Oral Wegovy Filing AcceptedBusiness — Aug 27, 2026Novo Nordisk trades near its average price target as China regulators accept the oral Wegovy application, underscoring a regulatory catalyst amid strong GLP-1 growth potential. The China market is heating up with Eli Lilly and others racing to offer pill-based options, and analysts project GLP-1 sales in China to surge to around 30 billion yuan in the next five to seven years, driving competition and market leadership shifts.

On X · @andTEAMofficial&TEAM Drops D-1 TikTok for “Mark on Me” Challenge Ahead of Mini Album ReleaseThe reaction to the &TEAM album teaser is overwhelmingly positive with no meaningful opposition or controversy; engagement is driven by fan enthusiasm.1,239 likes · 16m

The Dog Who Saved His Owner From a TrainGood News — FROM 2015A shelter dog named Lilly pulled her unconscious owner from railroad tracks and shielded her as the train came — losing a leg, saving a life.

Video — YouTubeMystery Ghost Ball in Wrigley's Ivy...🤔💀Dugout Daze · 24.1M views · Aug 30, 2026

Louisiana Girl Dies of Brain-Eating Amoeba, First Since 2013 — Aug 23, 2026Eight-year-old Lillian Smart of Ruston, Louisiana died from a Naegleria fowleri brain infection believed to have been contracted while swimming in Lake Claiborne. Health officials note Naegleria fowleri infections are extremely rare and almost always fatal, with this case adding to Louisiana’s lethal history of the amoeba since 2011 as the community rallies in support.

VS BattleJim Carrey vs Adam SandlerRubber-faced mania versus deadpan slob comedy — two 90s comedy titans, two entirely different engines.Jim Carrey vs Adam Sandler · 146 votes — pick a side

FDA approves Alzheimer's blood test for age 40+ — Aug 24, 2026The FDA has cleared several Alzheimer’s blood tests, including PrecivityAD2 for adults 40 and older to aid diagnosis in symptomatic cognitive decline (not a general screening tool), and Elecsys pTau217 tests for those 55 and older to detect amyloid pathology and rule in or out Alzheimer's in various care settings, expanding access through Roche’s installed lab network and major providers. These tests, developed by Roche with Lilly and by other providers, aim to simplify early diagnosis and broaden eligibility for related treatments and care pathways.

Novo Nordisk Tests Lower Wegovy Doses — Aug 19, 2026Novo Nordisk is conducting a late-stage study to identify the lowest effective dose of Wegovy, testing two low doses against placebo in 450 participants as it seeks to preserve its share in a obesity drug market projected to exceed $100 billion annually by 2030. The trial, which began on August 12 and runs through 2028, follows competitive pressure from Eli Lilly and comes after Wegovy's recent sales performance, with dose strengths undisclosed.

Nestlé Uses AI to Target GLP-1 UsersHealth — Aug 14, 2026The rapid rise of GLP-1 weight‑loss drugs is reshaping the market as Nestlé leverages AI to turn potential threats into opportunities by developing nutrition products and addressing drug side effects, while major pharma players like Lilly and Novo Nordisk navigate revenue trajectories and competitive disputes. Across the industry, executives see GLP-1 therapies expanding beyond weight loss into broader health benefits, with AstraZeneca highlighting broader applications and regulators flagging safety and counterfeit risks as demand climbs.

Daily Caller News FoundationAt Least Five Dead, Five Injured In Fatal Amazon Plane CrashAt least five people were killed and five others were injured Sunday after an Amazon cargo plane overran a runway when landing at a Florida airport.10h

BMS to Build $2.3B Houston Campus; Lilly Expands — Aug 10, 2026Bristol Myers Squibb is investing about $2.3 billion to build a 600,000-square-foot modular, multi-modal manufacturing campus at Generation Park in Houston, part of its $40 billion five-year U.S. investment plan, to produce small molecules, biologics, and antibody-drug conjugates while enabling future expansion. The project will create roughly 500 permanent jobs and about 2,000 construction roles through 2030, supported by Texas incentives, as drugmakers continue expanding domestic manufacturing under government pressure to boost U.S. production.

QuizThe Four-Letter Type TestThe classic sixteen-types test — twenty questions, four axes, your letters computed for real, and an AI portrait written for your exact mix.4 min · today's quiz

UK Approves Foundayo Oral GLP-1 Pill; NHS Decision Pending — Aug 10, 2026The UK has become the first European nation to approve Eli Lilly’s Orforglipron, sold as Foundayo, a once-daily GLP-1 pill for weight management and type 2 diabetes with specific BMI criteria and a multi-dose ramp-up. The MHRA emphasized prescription-only status and ongoing safety reviews, with NHS access still under consideration by NICE and not yet widely available.

Insurers, Medical Stocks Rally Ahead of EarningsBusiness — Jul 20, 2026From penny-stock hopefuls like Vizsla Silver and Clover Health to heavyweight medical names such as Danaher, Intuitive Surgical and Eli Lilly, investors are weighing high-growth potential against execution risk as volumes, profitability, and catalysts drive attention. Insurance stocks Cincinnati Financial, Reinsurance Group of America, Oscar Health, Willis Towers Watson and Aflac are poised to outperform, while Custom Health Holdings’ bid for Evergreen Pharmacy and Alnylam Pharmaceuticals’ RNAi-focused pipeline illustrate ongoing deal activity and biotech risk-reward in a rate-sensitive, geopolitically unsettled market.

Video — YouTubeDile A Tu Gato HoodtrapThery - Topic · 476.3K views · Sep 6, 2026

Mamdani Appoints Retired Lesbian As NYC Fire Commissioner — Dec 23, 2025New York City Mayor-elect Zohran Mamdani tapped retired New York City Fire Department (FDNY) veteran Lillian Bonsignore on Tuesday to lead the nation’s largest fire department. Bonsignore will become the department’s…

Trump Announces $250 Weight Loss Drugs In Latest ‘TrumpRx’ Deal — Nov 6, 2025President Donald Trump unveiled steep discounts on GLP-1 weight loss drugs in deals with pharmaceutical giants Eli Lilly and Novo Nordisk in a Thursday Oval Office announcement. The obesity drugs Zepbound, marketed by…

IJREnergy Secretary Gives Reality Check After US Military Takes Out Three Iranian Oil TankersSpencer Lombardo · 4 min · 19h

Father Of Co-Pilot Killed In DCA Crash Fights Tears, Finds Comfort Knowing His Son ‘Was Right With Jesus’ — Jan 31, 2025The father of 28-year-old PSA Airlines co-pilot Sam Lilley, who was killed in the deadly collision near Ronald Reagan Washington National Airport, appeared to fight back tears Thursday on NewsNation, saying his comfort…

Heartbreak as Former College Tennis Player Dies from Massive Heart Attack: ‘Heaven Gained Another Angel’Reporting — Feb 9, 2023Family members have been left stunned and devastated after a 31-year-old former college tennis star passed away from a sudden heart attack. Lilly Kimbell, a 2014 graduate of the University of Georgia, died on Sunday…

‘Cheers’ Star Kirstie Alley Dies at 71 After Battle With CancerReporting — Dec 6, 2022Actress Kirstie Alley has died at the age of 71. Alley’s children, True Parker and Lillie Parker, announced the news of her passing on her official Instagram page. “To all our friends, far and wide around the world … We…

Marvel Actor Attends Anti-Vaccine Rally in DC: I Support ‘Bodily Sovereignty’Reporting — Jan 28, 2022Actress Evangeline Lilly, known for being on the show “Lost,” and in Marvel’s “Ant-man and the wasp” attended an anti-vaccine rally in Washington, D.C. to support “bodily sovereignty.” “I believe nobody should ever be…

Lifeguard Makes Stunning First Rescue No One Saw Coming: WatchReporting — Jan 15, 2022There are few things more Australian than the story that took place on New Year’s Eve in Iluka, New South Wales. Lillian Bee Young, 17, a rookie lifeguard and aspiring professional surfer, was watching over the beach at…

On X · @JoshCullen_sSB19’s Josh Cullen Posts Teaser “Heard You’ve Been Waiting for Me,” Sparking Fan ExcitementJosh Cullen (@JoshCullen_s), member of Filipino P-pop group SB19, shared a short post with a photo and the caption “Heard you’ve been waiting for me. #JoshCullen.” Fans interpret it as a teaser for new solo music, a project, or a return/activity after a quieter period. It is trending within the A’TIN (SB19 fandom) due to rapid engagement (thousands of likes/reposts, hundreds of quotes/replies shortly after posting) and widespread speculation about an upcoming “JC era” or release.1,347 likes · 17m

Video — YouTubeMISTRIAL: Lindsay Clancy Murder Trial — MA v. Lindsay Clancy — Day 28Law&Crime Trials · 1.9M views · Sep 4, 2026